Objective : To characterize type 2 diabetes patients treated with GLP1 analogs in the outpatient clinic of endocrinology in Honduras Medical Center from 2016-2018.
This is a retrospective descriptive study, evaluating 29 patients with type 2 diabetes, collecting data from the medical files that was introduced to a SPSS data base. Data was analyzed using descriptive statistics and cross tabulations.
Results : Most 58.6% (n=17) were females, and 41.4% were males, with a mean age of 45. Twenty six (88.8%) of the studied patients have 10 years or less of type 2 diabetes diagnosis. The mean of time exposure to GLP1 was 14 months, with a mean of A1c at the beginning of the study was 7.69%, managing to accomplish a descent of 1.7% during the study. The mean weight of the studied patients was 97.2kg with a mean decrease of 2.5kg. The most frequent adverse effect was nausea, and there were no reported cases of hypoglycemia, pancreatitis, diarrhea, or infection on the injection site.
Discussion : The decrease in A1c is found to be within the expected range of descent (0.6-1.9%), and patients consistently presented gradual weight loss that was sustained during the duration of the study with minor adverse effects.
Conclusion : There have not been a lot of published experiences in latin american population living in central america with this new family of medications and this brief description seems to show a tendency that is in agreement with what is reported in world literature.
Maria Alejandra Ramos Guifarro– Chief of Endocrinology, Hospital Escuela Universitario, Tegucigalpa, Francisco Morazan, Honduras
Irma De Vicente– Internal Medicine, Hospital Escuela Universitario
Scarleth Betzabel Rodas– Medical Student, Universidad Nacional autonoma de Honduras
Daniel Andrés Guifarro Rivera– Medical Student, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Francisco Morazan, Honduras
Chief of Endocrinology
Hospital Escuela Universitario
Tegucigalpa, Francisco Morazan, Honduras
Chief of Endocrinology Hospital Escuela
Universidad Nacional autonoma de Honduras